Victorian Alzheimer’s disease trial

3 people holding hands
A Victorian patient with Alzheimer's disease has become the first in the world to be given a breakthrough new drug that experts hope will revolutionise treatment for the most common form of dementia.   Alfred Health was selected by the overseas drug company to lead the first trial on patients with the disease, giving Victorians

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacy of the Year finalists announced
Next Priceline Pharmacy spearheads API growth